Survey of Osteoarthritis Real World Therapies (MK-0663-140)

• Status: Completed
• Trial end date: 2013-01-01
• Target enrollment: 0
• Participant gender: All

Summary

This was a study to estimate the proportion of participants with osteoarthritis of the knee(s) who were treated with oral or topical analgesics for their symptoms, who did and did not report adequate pain relief at Baseline and to characterize their pain level over a 12-month follow-up period.

• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Merck Sharp & Dohme Corp.

Criteria

Inclusion Criteria:

• Clinical diagnosis of primary osteoarthritis of the knee(s)

• Presently receiving prescribed oral or topical analgesics for a minimum duration of two weeks prior to enrollment

Exclusion Criteria:

• Arthritis other than primary osteoarthritis

• Treatment with disease-modifying antirheumatic drugs (DMARDS), methotrexate or biologics

• Subtotal or total joint replacement in the affected knee

• Chronic severe pain of other causes that in the opinion of the investigator may require long-term analgesia or confound the present study

• Currently enrolled in a clinical trial or who have participated in a clinical trial within the past 30 days